Drug Development start up
Our vision is to improve the quality of life of millions of people around the world who suffer from chronic skin diseases such as psoriasis, atopic dermatitis, pruritus and more. Following the development and marketing of our first cosmetic product MiBiome, and based on the amazing results received from MiBiome users and physicians, we continue development processes to expand clinical trials, develop additional products tailored to different areas of the body and obtain the strictest regulatory approvals in the medical field. All this while leading and expanding groundbreaking scientific research in Israel and around the world in the field of dermal microbiome.
Along with the scientific vision, we operate to create quality jobs in northern Israel (periphery), promote women and populations ejected from the labor force, contribute to the development of the Galilee and later on other areas in the periphery, and make innovative products accessible to the world!
We are happy to announce that MIBIOMICS was accepted to participate in the 2020 MassChallenge Israel accelerator program!
MIBIOMICS is an innovative Israeli start up developing Microbiome Based Solutions. Our 1st prototype effectively treats chronic and incurable skin diseases like Psoriasis, Atopic Dermatitis and more. Our next challenges are to continue development, conduct additional clinical trials, gain regulatory approvals such as CE and FDA for medical products and expend portfolio to treat additional skin and respiratory diseases, such as COVID-19!
We are excited to announce that a panel of experts from the Israeli Ministry of Health and HealthIL, the digital health community has evaluated our solution and found it worthy of publishing it on the National Platform to enable cooperation between companies and health systems! We are well on our way to initiating a clinical trial with one of the leading Israeli hospitals! If you also dream of helping people – contact us for additional details!
Hula Valley – Community of Entrepreneurs in the Eastern Galilee – thank you for tremendous support!
The MIBIOMICS venture was selected to participate in China virtual roadshow (virtual due to the COVID-19 pandemic). It was a great opportunity to present our technology to the top investors and discuss the innovation in the dermal microbiome field!
Our venture is looking for an investment for further development of therapeutic products that manage human microbiome, conduct additional clinical trials and obtain regulatory approvals such as CE mark and FDA.
Join us and help to improve lives of millions of people who suffer from chronic and incurable skin diseases!